CL vs CSBR · P/E 34, rev $20.38B vs P/E 16, rev $56.9M
Colgate-Palmolive Company (CL) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the CL and CSBR stock pages for the full models.
Not investment advice.